I think cancer and Nash are our biggest revenue opportunities that we have actually announced and or started trials. However don’t think we could ever get to $400 billion. I think more realistically cancer, at some point, could be 15 -20 billion. Nash could be huge - possibly more than cancer. Say your $35 billon on these two alone that should equate to $140 billion MKT Cap